A new imaging device uses long-wavelength infrared imaging to detect small thermal radiation emitted from dental caries, allowing for earlier diagnosis and potential reversal. The tool has the benefits of being noncontact, noninvasive, and low-cost, with great potential as a commercially viable diagnostic imaging device.
A new imaging technique using tau PET has been confirmed to accurately depict changes in the brain associated with Alzheimer's disease. The method reveals tau protein accumulation, which is linked to cell death and can be targeted by new drugs.
CAS researchers have developed a new monomer fluorescent protein, Skylan-NS, enabling substantial improvements in the speed, duration, and noninvasiveness of live-cell superresolution microscopy. The protein shows high photostability, cycle numbers and signal-to-noise ratio, making it suitable for live-cell SR imaging.
A study found that biphenotypic primary liver carcinoma can be misclassified as hepatocellular carcinoma if only major imaging features are considered. The study suggests using a comprehensive algorithm for liver lesion assessment, such as Liver Imaging Reporting and Data Systems (LI-RADS), to accurately classify these malignancies.
The SNMMI-TS awarded Lynne Roy, Crystal Botkin, David Campbell, Marcia Hess Smith, Deborah Gibbs, Dmitry D. Beyder, and Aaron Scott for their exceptional contributions to the field of nuclear medicine technology, including education, service, and leadership.
A team of scientists developed a new approach to visualize oxygen in tissue, using optoacoustic methods and a novel algorithm that corrects for light propagation effects. This non-invasive imaging method achieves high accuracy and resolution, enabling the study of various medical conditions such as tumor growth and metabolism.
A new platform called spectroscopic photon localization microscopy (SPLM) increases the resolution of molecular imaging by fourfold, making it faster and simpler. This breakthrough can be applied to various fields like materials science and life sciences to study nanoscale environments.
A study of 28,000 patients found that increased imaging after initial treatment for thyroid cancer did not lead to better survival rates, but rather more aggressive treatment for recurrence. The researchers emphasize the importance of curbing unnecessary imaging and tailoring care to individual patient risk.
A new study found that while more imaging after thyroid cancer treatment identifies recurrence, it does not always lead to improved survival. Radioiodine scans, however, were associated with better outcomes.
Researchers at University of Missouri have developed a new, low-cost imaging platform that enables single molecule imaging with ordinary microscopes. The patented method uses surface plasmon resonance to achieve super-resolution imaging down to 65 nanometers.
A new PET/MRI imaging test has been shown to improve the detection of significant prostate cancer, surpassing current multi-parametric MRI methods. The test's addition of molecular imaging based on F-18-choline positron emission tomography (PET) significantly improves the identification of clinically significant cancers.
Researchers have developed a new device that enables existing breast cancer imagers to provide up to six times better contrast of tumors in the breast while maintaining the same or better image quality. The Variable Angle Slant Hole Collimator reduces radiation dose to patients by half, potentially improving imaging of other organs.
A new study by the Society of Nuclear Medicine and Molecular Imaging shows that PET/CT imaging using prostate-specific membrane antigen leads to highly accurate tumor detection and delineation, with a 67% accuracy rate.
The novel portable diagnostic tool offers a multi-dimensional look at the body by combining optical and gamma imaging, allowing physicians to visualize molecular data alongside surface organ images. Clinical pilot studies have shown promising results in imaging lymphatic and thyroid tissue, as well as tear ducts.
A new PET study reveals that tau protein tangles in the brain may be driving the neurodegeneration behind Alzheimer's disease. The research found a significant correlation between increased tau and decreased metabolic activity in the brain, suggesting that tau imaging could be used to detect neuronal injury earlier than amyloid imaging.
Researchers used PET and SPECT to tailor radionuclide treatment for neuroendocrine cancer patients, reducing the risk of toxicity. The study showed that personalized dosimetry led to a significant alteration in radiotherapy doses, with some patients receiving reduced or increased doses.
The Education and Research Foundation for Nuclear Medicine and Molecular Imaging honored Dr. H. William Strauss with the 2016 Benedict Cassen Prize for his seminal studies in cardiovascular nuclear medicine. This award recognizes his work that has greatly advanced nuclear medicine science and had a high clinical impact.
Peter S. Conti, MD, PhD, receives the prestigious Paul C. Aebersold Award for his groundbreaking work in developing novel diagnostic imaging agents for oncology applications. His research focuses on PET imaging and gene expression, advancing the field of nuclear medicine and molecular imaging.
A University of California San Diego study describes a new imaging biomarker that enhances MRI to differentiate aggressive prostate cancer from low-grade or benign tumors. The technology, called restriction spectrum imaging (RSI), allows for non-invasive detection and prediction of tumor grade without biopsy.
Researchers are developing imaging biomarkers and optical imaging tools to screen for ovarian cancer, a 'silent killer' of women. The goal is to enable early detection and save lives.
Scientists have developed a new imaging system that can produce three-dimensional images of the insides of arteries, revealing fatty arteries in all their detail. This breakthrough technology has the potential to help doctors diagnose plaque vulnerability in patients and better identify heart disease.
The European Association of Cardiovascular Imaging has released new guidelines for the imaging assessment of prosthetic heart valves. The guidelines provide recommendations for a multimodality approach to diagnose and manage complications, including echocardiography as the first-line imaging modality. The study aims to improve assessme...
Groundbreaking research in 13 radiology subspecialities presented during the ARRS 2016 Annual Meeting. Notable findings include improved prostate cancer detection and grading using restriction spectrum imaging, reduced unnecessary biopsies via novel mammographic algorithm, and faster knee MRI acquisition with accelerated SPACE.
This year's top winners include a study on benign disorders simulating thoracic malignancies and a thorough understanding of ankle nerves for nerve entrapment evaluation. B-flow imaging is also highlighted as a promising method to complement color Doppler ultrasound.
Scientists at the University of Nottingham have developed a process to create hyperpolarized krypton gas for MRI scanning of the lungs, offering a clearer picture of lung disease. This technology uses clean energy combustion to retain the hyperpolarized state of krypton during preparation.
Ultrawide field (UWF) scanning technology improved the ability to identify diabetic retinopathy in patients and judge the need for follow-up examinations or treatment. The study found that UWF imaging reduced ungradable images by 81% compared to traditional digital retinal photographs.
Researchers at NC State University have developed an algorithm that can quickly and accurately reconstruct hyperspectral images using less data. This breakthrough enables faster imaging times and reduced memory requirements, making it suitable for applications such as security, defense, environmental monitoring, and agriculture.
Researchers used a 7T MRI scanner to visualize myocardial injury in patients with hypertrophic cardiomyopathy, detecting minute clefts that were previously impossible to see. The technology offers high-resolution imaging and could lead to more accurate diagnoses of heart diseases.
Researchers demonstrate ghost imaging technique in time domain for ultrafast optical signals in optical fibers. The method enables reconstruction of perfect copies of ultrafast signals using correlation of intensity fluctuations and total power of modulated signals.
The American College of Cardiology and American College of Radiology have established recommendations for diagnosing chest pain in emergency departments. The guidelines assess the risks and benefits of diagnostic imaging procedures, providing guidance for clinicians to inform their judgment.
A study published in Medical Care found that patients with high-deductible insurance plans used fewer imaging tests and had lower costs for diagnostic imaging. However, the study could not determine whether this was due to high- or low-value utilization, raising concerns about potential drawbacks of high-deductible plans.
Patients with high-deductible health plans use 7.5% fewer diagnostic tests like MRI, X-rays, and CT scans than those without such plans. High-deductible plans may discourage test use due to lack of informed decision-making by patients.
The new risk management plan aims to prioritize data quality, reduce costs, and decrease attrition rates in imaging biomarker-driven trials. By identifying risks at trial initiation and allocating resources effectively, the framework can help minimize variability and ensure reproducibility of data.
MIT researchers develop a low-cost biomedical imaging system using fluorescence lifetime imaging and Fourier transform analysis, enabling accuracy comparable to expensive lab equipment.
Researchers at Georgia State University developed a new imaging agent, ProCA1.GRPR, which effectively traces changes in cancers and targets diseased cells without radiation limitations. The agent demonstrates strong tumor penetration and shows promise for improved cancer diagnosis and treatment outcomes.
Researchers at City College of New York have introduced a new optical window, dubbed the Golden Window, which enables deeper brain tissue imaging. This breakthrough has significant implications for the noninvasive study of the brain and breasts, reducing scattering that causes blurring in previous methods.
Researchers have developed a new noninvasive light-based imaging technology that can see inside the living brain, providing a tool to study how diseases change brain tissue over time. The method doubles the image depth range, enabling examination of acute and chronic morphological or functional vascular changes in the deep brain.
An analysis of seven clinical services found significant declines in imaging for headaches and cardiac imaging in low-risk patients. The study, part of the Choosing Wisely campaign, aimed to reduce unnecessary medical procedures and treatments.
In Trinidad and Tobago, ballistic imaging technology was hindered by inefficient processes, backlogs, and delayed information transmission. The country's Integrated Ballistics Information System (IBIS) generated few hits due to database delays and insufficient evidence input.
Researchers at EPFL have created a groundbreaking DNA stain called SiR-Hoechst, which enables the safe imaging of living cells for extended periods. This innovation allows biologists to track biological processes such as cell division in real-time, paving the way for further breakthroughs in bioimaging.
A new imaging technique found damage to nerve tracts connecting different parts of the brain in people with high blood pressure, linked to difficulties in cognitive skills and emotional regulation. DTI provides a way to evaluate pre-symptomatic brain damage in people with high blood pressure.
Research published in the International Journal of Biomedical Engineering and Technology reveals a wavelet transform approach that improves medical imaging. The technique boosts the signal-to-noise ratio and reduces artifacts, allowing for earlier disease detection and diagnosis.
Researchers at the Howard Hughes Medical Institute's Janelia Research Campus have developed new imaging techniques that dramatically improve spatial resolution in living cells. The new methods offer extraordinary visual detail of structures inside cells with unprecedented clarity and speed.
The University of Oklahoma is developing a faster, more advanced imaging radar to provide unprecedented resolution and flexibility in storm surveillance. The new system will enable scientists to study tornadoes, hurricanes, lightning, and other phenomena on an incredible time and spatial scale.
Researchers developed a molecular imaging biomarker that detects fast-growing primary prostate cancer and distinguishes it from benign prostate lesions. The new PSMA-based PET imaging technique was more specific than MR imaging for detecting clinically significant high-grade prostate cancer lesions.
Researchers developed a new biomarker that uses magnetic resonance imaging (MRI) to detect micrometastases, tiny tumor cells with the potential to develop into secondary breast cancer tumors. This approach may offer an improved way to detect early recurrence of breast cancer in women and men.
Researchers from Université de Genève found that activated neurons swell due to massive entry of water, providing a new insight into brain functioning. This discovery enables the detection of cellular mechanisms behind brain activity, allowing for more accurate localization and pathologies diagnosis.
The hospital has successfully integrated two common imaging techniques to produce a three-dimensional anatomic model of a patient's heart. The technology combines computed tomography (CT) and magnetic resonance imaging (MRI) with echocardiography, enabling more accurate diagnoses and treatment plans.
Scientists have developed nanoscale hybrid materials for noninvasive cancer diagnosis, offering improved image resolution and minimal toxicity. These hybrid materials combine strong fluorescence, high photostability, and great biocompatibility, making them promising for clinical bioimaging applications.
A study found that 86% of women with early-stage breast cancer in Ontario underwent imaging to detect metastatic cancer, despite international guidelines recommending against it. The use of advanced imaging increased and varied by geographic region and hospital type, highlighting a need for improved knowledge translation strategies.
RIT professor Hans Schmitthenner is designing molecular imaging compounds that selectively target prostate cancer cells, using contrast dyes for improved detection. The preclinical phase project aims to enhance image-directed biopsies, potentially reducing pain and side effects.
A new study found that PET/CT scans are highly sensitive for detecting relapsed non-Hodgkin lymphoma, with a sensitivity rate of 95.1%. This breakthrough has significant implications for patient care, as early diagnosis can lead to improved treatment outcomes and longer survival rates.
The hybrid scanner combines conventional MRI, hyperpolarized MRI, positron imaging, luminescence imaging, and fluorescence microscopy to provide high-resolution multimodal intra-vital imaging. This allows researchers to study tumor biology and develop targeted therapies by analyzing the co-registration of multiple imaging data lines.
A specialized PET tracer has been developed to visualize the function of nerve cells that lead to neuronal loss and cognitive decline in neurodegenerative diseases. The tracer binds to a transporter of the neurotransmitter acetylcholine, allowing for the quantification of cholinergic neuron loss and its effects on cognition.
A new molecular imaging agent has been developed to detect prostate cancer that has spread to other tissues. The agent targets the PSMA enzyme, which is associated with prostate cancer, and has shown high accuracy in detecting disease sites, including those not identified by conventional methods.
Scientists have developed a novel PET tracer that can pinpoint thrombi throughout the body with over 97% accuracy. The tracer, Cu-64 FBP8, targets fibrin in blood clots and reflects thrombus age, enabling clinicians to choose more effective treatments.
A new technique combines dynamic PET imaging with parametric tumor mapping to detect tumors and metastases throughout the body, providing quantitative evaluation and improved contrast. This method has the potential to be used for early diagnosis and more accurate prognosis of various cancers.
Researchers have developed a cloud-based software that analyzes and standardizes PET imaging data, allowing for earlier and more accurate diagnoses of Alzheimer's disease. The program uses machine learning to compare patients' scans with normal and abnormal scans, providing consistent results and quantifying PET data accurately.
Researchers used PET/CT with Ga-68 DOTATOC to detect primary tumors in patients with metastatic neuroendocrine cancer. The study found that 28% of patients underwent a major change in cancer management due to the imaging technique.
A new molecular imaging scan detects dangerous protein deposits in the heart, significantly increasing cardiac risk. The scan uses a widely available agent to assess amyloid buildup and predict future heart attacks.